John Wiley & Sons (NYSE:WLY – Get Free Report) and Haoxi Health Technology (NASDAQ:HAO – Get Free Report) are both communication services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.
Volatility and Risk
John Wiley & Sons has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, Haoxi Health Technology has a beta of -1.13, meaning that its stock price is 213% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings for John Wiley & Sons and Haoxi Health Technology, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| John Wiley & Sons | 0 | 1 | 1 | 0 | 2.50 |
| Haoxi Health Technology | 1 | 0 | 0 | 0 | 1.00 |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| John Wiley & Sons | $1.68 billion | 1.63 | $221.62 million | $4.23 | 12.72 |
| Haoxi Health Technology | $32.80 million | 0.04 | $3.88 million | N/A | N/A |
John Wiley & Sons has higher revenue and earnings than Haoxi Health Technology.
Insider and Institutional Ownership
73.9% of John Wiley & Sons shares are owned by institutional investors. 17.6% of John Wiley & Sons shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares John Wiley & Sons and Haoxi Health Technology’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| John Wiley & Sons | 13.22% | 29.01% | 8.78% |
| Haoxi Health Technology | N/A | N/A | N/A |
Summary
John Wiley & Sons beats Haoxi Health Technology on 11 of the 11 factors compared between the two stocks.
About John Wiley & Sons
John Wiley & Sons, Inc. engages in the provision of research and learning materials. It operates through the following segments: Research, Learning, and Held for Sale or Sold. The Research segment consists of research publishing and research solutions. The Learning segment includes academic and professional reporting lines and consists of publishing and related knowledge solutions. The Held for Sale or Sold segment offers businesses held-for-sale including Wiley Edge and CrossKnowledge, University Services and Tuition Manager, and Test Prep and Advancement Courses. The company was founded by Charles Wiley in 1807 and is headquartered in Hoboken, NJ.
About Haoxi Health Technology
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.
Receive News & Ratings for John Wiley & Sons Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for John Wiley & Sons and related companies with MarketBeat.com's FREE daily email newsletter.
